Replies to post #355 on Contrafect Corp (CFRX)

[drkazmd65]

Phase II testing is just that - Phase II testing. Until this company gets something completely past a Phase III and are preparing their BLA and data package to the FDA,... they are still a risky (risk is a two sided sword) bet.

Now - that having been said - CFRX has narrowed the range of that risk considerably by having what appear to be quite successful Phase II clinical results,...

That also having been said - I'll be looking to opportunistically add sets of shares here, and at a couple of other similarly positioned biotech companies through the winter. I don't really trade in and out much. I just find something that looks like it has some potential a year or so down the road, buy some of it cheap, and sit on it for a while.